CENTOGENE AG has a total of 66 patent applications. It decreased the IP activity by 30.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are CENTOGENE GMBH, CELL2IN INC and PUSCHETT JULES B.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 11 | |
#3 | Canada | 9 | |
#4 | WIPO (World Intellectual Property Organization) | 9 | |
#5 | Brazil | 6 | |
#6 | Israel | 6 | |
#7 | Japan | 5 | |
#8 | China | 3 | |
#9 | Mexico | 3 | |
#10 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks | |
#6 | Electrical machinery and energy |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Heterocyclic compounds | |
#6 | Microorganisms | |
#7 | Enzymes | |
#8 | Electric discharge tubes |
# | Name | Total Patents |
---|---|---|
#1 | Rolfs Arndt | 35 |
#2 | Mascher Hermann | 26 |
#3 | Cozma Claudia | 13 |
#4 | Arndt Rolfs | 11 |
#5 | Pews-Davtyan Anahit | 7 |
#6 | Lukas Jan | 7 |
#7 | Beller Matthias | 7 |
#8 | Junghanss Christian | 7 |
#9 | Hermann Mascher | 6 |
#10 | Frech Moritz | 6 |
Publication | Filing date | Title |
---|---|---|
EP3521828A1 | Method for the diagnosis of hereditary angioedema | |
EP3264092A1 | Use of lyso-gb1 as druggable target | |
WO2016078762A1 | Method for the diagnosis of niemann-pick disease using a biomarker | |
EP3115786A1 | Method for the diagnosis of farber's disease | |
WO2014183873A1 | Method for the diagnosis of niemann-pick disease | |
EP2932274A1 | Method for the diagnosis of metachromatic leukodystrophy | |
US2015306070A1 | Use of maleimide derivatives for preventing and treating leukemia | |
CA2892921A1 | Use of maleimide derivatives for preventing and treating cancer | |
AU2012339149A1 | Method for the diagnosis of Niemann-Pick disease |